| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | selumetinib:PLX-4032 (8:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.25 | 5e-11 |
| mRNA | RDEA119 | GDSC1000 | pan-cancer | AAC | -0.2 | 2e-10 |
| mRNA | PD-0325901 | GDSC1000 | pan-cancer | AAC | -0.22 | 3e-10 |
| mRNA | PX-12 | CTRPv2 | pan-cancer | AAC | 0.19 | 8e-10 |
| mRNA | Cytarabine | CTRPv2 | pan-cancer | AAC | 0.18 | 1e-09 |
| mRNA | FK866 | GDSC1000 | pan-cancer | AAC | 0.19 | 2e-09 |
| mRNA | SRT-1720 | CTRPv2 | pan-cancer | AAC | 0.24 | 2e-09 |
| mRNA | CUDC-101 | GDSC1000 | pan-cancer | AAC | 0.19 | 4e-09 |
| mRNA | AZD6244 | CTRPv2 | pan-cancer | AAC | -0.22 | 4e-09 |
| mRNA | NPK76-II-72-1 | GDSC1000 | pan-cancer | AAC | 0.18 | 9e-09 |